Novartis Zelnorm patient information (correction)
Executive Summary
Novartis has agreed to assess the distribution of patient prescribing information as a Phase IV commitment required for approval of its chronic constipation indication. "The Pink Sheet" had incorrectly reported that the company would assess the distribution of Zelnorm "Medguides" (1"The Pink Sheet" Aug. 30, 2004, p. 8). Zelnorm is not required to be distributed with a Medguide...
You may also be interested in...
Novartis To Assess Zelnorm “Medguide” Distribution In Phase IV Study
Novartis will create a protocol to assess the distribution of the Zelnorm "Medguide" to patients as one Phase IV commitment following FDA approval of a chronic idiopathic constipation indication
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.